Press Release Mar 02 2023
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release announcing that it received final approval from the USFDA for Acyclovir Cream. The cream is used to treat cold sores caused by the herpes simplex virus and will soon be launched in the US market. The product will be manufactured at Zydus's facility in Ahmedabad, India.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Feb 28 2023
- Press Release Feb 24 2023
- Press Release Feb 20 2023
- Press Release Feb 17 2023
- Press Release Feb 15 2023
Later from Zydus Lifesciences
- Press Release Mar 03 2023
- Press Release Mar 07 2023
- Press Release Mar 09 2023
- Zydus Lifesciences Limited Press Release Mar 15 2023
- Press Release Mar 21 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences